Dow Down0.48% Nasdaq Up0.29%

Skystar Bio Pharmaceutical Company (SKBI)

-NasdaqCM
0.16 0.00(0.00%) May 31, 2:41PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 18,353   14,240   6,833   9,625  
Cost of Revenue9,590  7,881  4,009  4,906  
Gross Profit 8,763   6,359   2,823   4,720  
Operating Expenses
Research Development378  799  4  538  
Selling General and Administrative2,985  2,192  1,647  1,523  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 5,400   3,368   1,172   2,659  
Income from Continuing Operations
Total Other Income/Expenses Net475  262  309  322  
Earnings Before Interest And Taxes5,875  3,630  1,481  2,981  
Interest Expense252  137  76  47  
Income Before Tax5,622  3,493  1,405  2,934  
Income Tax Expense713  682  430  601  
Minority Interest -   -   -   -  
Net Income From Continuing Ops4,909  2,811  975  2,332  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 4,909   2,811   975   2,332  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 4,909   2,811   975   2,332  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.